Neuroadaptive responses in brainstem noradrenergic nuclei following chronic morphine exposure

Molecular Neurobiology

Volumn 23, Issue 2-3, 2001, Pages 155-171

  Van Bockstaele, Elisabeth J ^a   Sue Menko, A ^a   Drolet, Guy ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Enkephalin; Glutamate; Locus coeruleus; Nucleus of the solitary tract; Opiates; Opioid receptors

Indexed keywords

ENKEPHALIN; GLUTAMIC ACID; MORPHINE; OPIATE RECEPTOR;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; LOCUS CERULEUS; LONG TERM EXPOSURE; NERVE CELL NETWORK; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; OPIATE ADDICTION; PROTEIN SECRETION; RAT; SOLITARY TRACT NUCLEUS; WITHDRAWAL SYNDROME;

EID: 0034756369     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:23:2-3:155     Document Type: Article

References (90)

1. Mechanisms of tolerance and dependence: An overview
2. Social, motor, and autonomic signs of morphine withdrawal: Differential sensitivities to catecholaminergic drugs in mice
3. Neural substrates of opiate withdrawal
4. Cellular and synaptic adaptations mediating opioid dependence
5. Neuroanatomical sites of action of clonidine in opiate withdrawal: The locus coeruleus connection
6. Heroin addicts have increased platelet alpha2-adrenoceptor densities which correlate with the severity of the abstinence syndrome
7. Pertussis toxin blocks the outward currents evoked by opiate and alpha2-agonists in locus coeruleus neurons
8. Local opiate withdrawal in locus coeruleus in vivo
9. CREB (cAMP response element-binding protein) in the locus coeruleus: Biochemical, physiological, and behavioral evidence for a role in opiate dependence
10. Monoamine metabolism in the locus coeruleus measured concurrently with behavior during opiate withdrawal: An in vivo microdialysis study in freely moving rats
11. Involvement of locus coeruleus projections in opiate withdrawal but not in opiate tolerance in mice
12. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal
13. Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats
14. Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal
15. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal
16. Long-term glutamate desensitization in locus coeruleus neurons and its role in opiate withdrawal
17. Lesions to terminals of noradrenergic locus coeruleus neurons do not inhibit opiate withdrawal behaviour in rats
18. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: An in vivo microdialysis study
19. Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: Studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals
20. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal
21. Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats
22. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input
23. Behavior of monkeys during opiate withdrawal and locus coeruleus stimulation
24. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus
25. Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain
26. Opiate withdrawal and the rat locus coeruleus: Behavioral, electrophysiological, and biochemical correlates
27. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal by clonidine
28. In vivo monoamine release during naloxone precipitated withdrawal
29. Clonidine reversal of increased noradrenaline metabolite levels during morphine withdrawal
30. Where is the locus in opioid withdrawal?
31. Total neurochemical lesion of noradrenergic neurons of the locus coeruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal
32. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
33. Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat
34. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration
35. The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal
36. Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal
37. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats
38. Immediate early gene expression during morphine withdrawal
39. Expression of c-fos protein in brain: Metabolic mapping at the cellular level
40. Expression of ofos protein in brain: Metabolic mapping at the cellular level
41. Induction of c-fos-like protein within the lumbar spinal cord and thalamus of the rat following peripheral stimulation
42. Collateralized projections from neurons in the rostral medulla to the nucleus locus coeruleus, the nucleus of the solitary tract and the periaqueductal gray
43. Activation of locus coeruleus neurons by nucleus paragigantocellularis or noxious sensory stimulation is mediated by intracoerulear excitatory amino acid neurotransmission
44. Two physiologically distinct populations of neurons in the ventrolateral medulla innervate the locus coeruleus
45. Activation of locus coeruleus from nucleus paragigantocellularis: A new excitatory amino acid pathway in brain
46. A potent excitatory input to the nucleus locus coeruleus from the ventrolateral medulla
47. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat
48. Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: Attenuation by lesions of the nucleus paragigantocellularis
49. Robust enkephalin innervation of the locus coeruleus from the rostral medulla
50. Evidence for coexistence of enkephalin and glutamate in axon terminals and cellular sites for functional interactions of their receptors in the rat locus coeruleus
51. Systemic naloxone administration potentiates locus coeruleus noradrenergic neuronal activity under stressful but not non-stressful conditions
52. Potentiation of enkephalin action by peptidase inhibitors in rat locus ceruleus in vitro
53. The contribution of nucleus reticularis paragigantocellularis and nucleus raphe magnus to the analgesia produced by systemically administered morphine, investigated with the microinjection technique
54. Tonic vasomotor control by the rostral ventrolateral medulla: Effect of electrical or chemical stimulation of the area containing C1 adrenaline neurons on arterial pressure, heart rate, and plasma catecholamines and vasopressin
55. Response properties and functional organization of neurons in midline regions of medullary reticular formation of cats
56. Effects of morphine and morphine withdrawal on adrenergic neurons of the rat rostral ventrolateral medulla
57. The nucleus paragigantocellularis and opioid withdrawal-like behavior
58. Regulation of G proteins by chronic morphine in the rat locus coeruleus
59. Second messenger and protein phosphorylation mechanisms underlying opiate addiction: Studies in the rat locus coeruleus
60. Molecular and cellular mechanisms of opiate action: Studies in the rat locus coeruleus
61. The neurobiology of drug addiction
62. Morphologically heterogeneous met-enkephalin terminals form synapses with tyrosine hydroxylase-containing dendrites in the rat nucleus locus coeruleus
63. Electron microscopic evidence for coexistence of leucine5-enkephalin and gamma-aminobutyric acid in a subpopulation of axon terminals in the rat locus coeruleus region
64. Evidence for opioid projections from the rostral ventral medulla to the nucleus of the solitary tract in rat brain
65. Decreases in endogenous opioid peptides in the rat medullo-coerulear pathway after chronic morphine treatment
66. Locus ceruleus discharge characteristics of morphine-dependent rats: Effects of naltrexone
67. Opposing regulation of the locus coeruleus by corticotropin releasing factor and opioids: Potential for reciprocal interactions between stress and opioid sensitivity
68. Seizure-induced alterations in the metabolism of hippocampal opioid peptides suggest opioid modulation of seizure-related behaviors
69. Relationship between hippocampal opioid peptides and seizures
70. Methionine-enkephalin concentrations in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and abstinent rats
71. Beta-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats
72. Modulation of preproenkephalin mRNA levels in brain regions and spinal cord of rats treated chronically with morphine
73. Effect of morphine on proenkephalin gene expression in the rat brain
74. Enkephalin: Radioimmunoassay and radioreceptor assay in morphine dependent rats
75. Stability of Met-enkephalin content in brain structures of morphine-dependent or foot shock-stressed rats
76. Radioimmunoassay of enkephalins. Regional distribution in rat brain after morphine treatment and hypophysectomy
77. A cyclic AMP-and phorbol ester-inducible DNA element
78. The effect of depolarization on expression of the human proenkephalin gene is synergistic with cAMP and dependent upon a cAMP-inducible enhancer
79. Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription
80. An AP-2 element acts synergistically with the cyclic AMP- and phorbol ester-inducible enhancer of the human proenkephalin gene
81. Analysis of the proenkephalin second messenger-reducible enhancer in rat striatal cultures
82. Drug addiction: A model for the molecular basis of neural plasticity
83. Inhibition of morphine tolerance and dependence by diazepam and its relation to cyclic AMP levels in discrete rat brain regions and spinal cord
84. Changes in hypothalamic preproenkephalin A mRNA following stress and opiate withdrawal
85. Chronic naltrexone treatment increases expression of preproenkephalin and preprotachykinin mRNA in discrete brain regions
86. Morphine alters preproenkephalin gene expression
87. Regional changes in sympathetic nerve activity and baroreceptor reflex function and arterial plasma levels of catecholamines, renin and vasopressin during naloxone precipitated morphine withdrawal in rats
88. Delta-opioid receptor is present in presynaptic axon terminals in the rat nucleus locus coeruleus: Relationships with methionine5-enkephalin
89. Ultrastructural evidence for prominent distribution of the mu-opioid receptor at extrasynaptic sites on noradrenergic dendrites in the rat nucleus locus coeruleus